CURLF (Curaleaf Holdings) Growth Rank: 7 (As of Jul. 08, 2026) — 13% Below Median


CURLF Curaleaf Holdings Inc CURLF
67 GF Score
Price $9.35
GF Value $7.98
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings Growth Rank?

Curaleaf Holdings CURLF -0.53% 67 Growth Rank is 7 as of Jul. 08, 2026, which is 13% below its 10-year median of 8.00. GuruFocus rates CURLF with a GF Score™ of 67/100 and a GF Value™ of $7.98 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Curaleaf Holdings has the Growth Rank of 7.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Curaleaf Holdings Growth Rank Related Terms

CURLF vs ZTS, UTHR: Growth Rank Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaleaf Holdings Growth Rank vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Growth Rank falls into.


CURLF
67GF Score
Curaleaf Holdings Inc CURLF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 7 mean?
Curaleaf Holdings (CURLF) has a Growth Rank of 7 as of Jul. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Curaleaf Holdings and its competitors. This is 13% below median its historical median of 8.00. Over the past decade, Curaleaf Holdings' Growth Rank has ranged from 4.00 to 10.00.
Is Curaleaf Holdings' Growth Rank too high?
Curaleaf Holdings' current Growth Rank of 7 is 13% below median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 10.00. Overall, Curaleaf Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Growth Rank compare to ZTS and UTHR?
Curaleaf Holdings' Growth Rank of 7 can be compared against companies in the Drug Manufacturers industry. Historically, Curaleaf Holdings' own Growth Rank has ranged from 4.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Drug Manufacturers company?
A good Growth Rank depends on the Drug Manufacturers industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Curaleaf Holdings and its competitors. Curaleaf Holdings's current Growth Rank is 7, which is 13% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (CURLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $7.98, compared to a current price of $9.35 — trading 17.2% above its estimated fair value. The current Growth Rank is 7, which is 13% below median its 10-year median of 8.00. Curaleaf Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Curaleaf Holdings (CURLF), the current Growth Rank is 7 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (CURLF) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of $9.35 is trading 17.2% above its estimated GF Value™ of $7.98. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for CURLF:

  • Growth Rank: 7 (13% below median its 10-year median of 8.00)
  • GF Value™: $7.98 vs. price of $9.35 (17.2% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the CURLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curaleaf Holdings Business Description

Other Exchanges 2XW:GermanyCURA:Canada
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
67GF Score

Get the complete analysis for CURLF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.35
Price
$7.98
GF Value